SCHEMBL342300

SCHEMBL342300

CC(C)(C=O)CNCC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.48
ADH1C P00326 1/20 0.48
ADH1A P07327 1/20 0.48
ADH4 P08319 1/20 0.48
ADH7 P40394 1/20 0.48
EPHX1 P07099 3/20 0.40
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
CA9 Q16790 1/20 0.38
HDAC6 Q9UBN7 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
CYP2D6 P10635 1/20 0.37
MLYCD O95822 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24842175 0.79 ADH1B (0.45) ADH1BADH1CADH1AADH4ADH7
SCHEMBL7289554 0.78 ADH1B (0.43) ADH1BADH1CADH1AADH4ADH7
SCHEMBL25006761 0.77 ADH1B (0.41) ADH1BADH1CADH1AADH4ADH7
SCHEMBL15114154 0.76 ADH1B (0.42) ADH1BADH1CADH1AADH4ADH7
SCHEMBL7353900 0.75 ADH1A (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL30841896 0.75 ADH1B (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL98092 0.75 ADH1A (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL23137867 0.74 ADH1B (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL9935970 0.74 ADH1B (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL15114124 0.74 ADH1B (0.41) ADH1BADH1CADH1AADH4ADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651876-B1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECH AG (CH) 2017-08-09 EP claimed
CN-103313995-B Secondary aminosilanes SIKA技术股份公司 2016-08-10 CN claimed
US-8877955-B2 Secondary aminosilanes SIKA TECHNOLOGY AG (CH) 2014-11-04 US claimed
US-20130281562-A1 SECONDARY AMINOSILANES SIKA TECHNOLOGY AG (CH) 2013-10-24 US claimed
EP-2651956-A1 SECONDARY AMINOSILANES Sika Technology AG (CH) 2013-10-23 EP claimed
EP-2651876-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS Sika Technology AG (CH) 2013-10-23 EP claimed
US-20130261270-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECHNOLOGY AG (CH) 2013-10-03 US claimed
EP-2468759-A1 Secondary Aminosilanes Sika Technology AG (CH) 2012-06-27 EP claimed
WO-2012080266-A1 SECONDARY AMINOSILANES SIKA TECHNOLOGY AG (CH) 2012-06-21 WO claimed
WO-2012080265-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECHNOLOGY AG (CH) 2012-06-21 WO claimed
EP-2465843-A1 Polyamines with secondary aliphatic amines Sika Technology AG (CH) 2012-06-20 EP claimed
US-20260139170-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION SIKA TECHNOLOGY AG (CH) 2026-05-21 US disclosed
EP-4626995-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION Sika Technology AG (CH) 2025-10-08 EP disclosed
EP-3484898-B1 METHOD OF STABILIZING IMINO-FUNCTIONAL SILANE MOMENTIVE PERFORMANCE MAT INC (US) 2023-06-28 EP disclosed
EP-4053134-A1 METHOD OF STABILIZING IMINO-FUNCTIONAL SILANE Momentive Performance Materials Inc. (US) 2022-09-07 EP disclosed
EP-2236535-A1 Humidity curing polyurethane composition being accelerated by influence of heat Sika Technology AG (CH) 2010-10-06 EP disclosed
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE SIKA TECHNOLOGY AG (CH) 2010-04-29 US disclosed
EP-2178828-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDAMINE Sika Technology AG (CH) 2010-04-28 EP disclosed
WO-2009010522-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDAMINE SIKA TECHNOLOGY AG (CH) 2009-01-22 WO disclosed
EP-2017260-A1 Aldimines and compounds containing aldimine Sika Technology AG (CH) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281562-A1 SECONDARY AMINOSILANES AS3MT, SRM, MSN ADH1B 4383/4885ADH1C 4472/4885ADH1A 3967/4885
US-20260139170-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION DDAH1, ACMSD, APEH ADH1B 2450/4885ADH1C 160/4885ADH1A 47/4885
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE ALDH7A1, ILK, ALDH3A1 ADH1B 69/4885ADH1C 108/4885ADH1A 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.